Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

If a scan conducted during the study shows that (compared to baseline) your cancer has significantly grown or your blood tests or symptoms suggest the study drug is not working, we will discontinue the study. This means we will stop giving you the study treatment. We will arrange at least one other appointment to reassess you after you have stopped the study and will refer you back to your main oncologist. If you are keen to try another clinical study, we will add your name to our trials waiting list and let you and your oncologist know if another study becomes available in the future.